Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 11/20 | 0.60 |
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | PPARA | Q07869 | 4/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6958822 | 0.91 | FFAR1 (0.52) | FFAR1MAOBPPARGPPARACYP3A4 | |
| SCHEMBL6963885 | 0.88 | FFAR1 (0.53) | FFAR1MAOBPPARGPPARACYP3A4 | |
| SCHEMBL6964001 | 0.87 | PPARG (0.56) | FFAR1MAOBPPARGPPARACYP3A4 | |
| SCHEMBL377641 | 0.87 | FFAR1 (0.59) | FFAR1PPARGPPARACYP3A4 | |
| SCHEMBL29602962 | 0.87 | FFAR1 (0.59) | FFAR1PPARGPPARACYP3A4 | |
| SCHEMBL6958784 | 0.86 | FFAR1 (0.58) | FFAR1PPARGPPARACYP3A4RXRA | |
| SCHEMBL6956120 | 0.86 | FFAR1 (0.63) | FFAR1PPARGPPARA | |
| SCHEMBL6955421 | 0.84 | FFAR1 (0.47) | FFAR1PPARGPPARA | |
| SCHEMBL6959296 | 0.84 | FFAR1 (0.51) | FFAR1MAOBPPARGPPARACYP3A4 | |
| SCHEMBL6964661 | 0.82 | FFAR1 (0.51) | FFAR1PPARGPPARACYP3A4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0787725-B1 | QUINOLINE DERIVATIVE | NIPPON CHEMIPHAR CO (JP) | 2003-04-23 | — | — | EP | claimed |
| WO-2009043593-A1 | COMBINATION THERAPY USING MEMANTINE AND GLITAZONES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-04-09 | — | — | WO | disclosed |
| EP-0974348-B1 | VISCERAL FAT LOWERING AGENT | NIPPON CHEMIPHAR CO (JP) | 2008-07-02 | — | — | EP | disclosed |
| EP-0787725-B1 | QUINOLINE DERIVATIVE | NIPPON CHEMIPHAR CO (JP) | 2003-04-23 | — | — | EP | disclosed |
| US-6121288-A | DECREASING VISCERAL FAT, INHIBITING ACCUMULATION OF VISCERAL FAT AND IMPROVING THE DISTRIBUTION OF VISCERAL FAT BY ADMINISTERING A 5-SUBSTITUTED-2,4-THIAZOLIDINEDIONE DERIVATIVE OF GIVEN FORMULA | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
| EP-0974348-A1 | VISCERAL FAT LOWERING AGENT | NIPPON CHEMIPHAR CO., LTD. (JP) | 2000-01-26 | — | — | EP | disclosed |
| EP-0787725-A1 | QUINOLINE DERIVATIVE | NIPPON CHEMIPHAR CO., LTD. (JP) | 1997-08-06 | — | — | EP | disclosed |